Literature DB >> 11012210

The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production.

R A Shivdasani1.   

Abstract

To determine the in vivo functions of the transcription factor NF-E2, we have disrupted the gene encoding its hematopoietic-specific p45 subunit in embryonic stem cells and generated knockout mice. These animals have a surprisingly mild erythroid cell abnormality but experience lethal hemorrhage as a result of profound thrombocytopenia. Impaired platelet formation is secondary to a cytoplasmic maturation arrest within megakaryocytes, characterized by a marked reduction in granule numbers. Although the proliferative response to recombinant thrombopoietin is intact, this is not accompanied by correction of the differentiation defect. Absence of the smaller (p18) subunit of NF-E2 does not have similar consequences. These findings implicate target genes of the NF-E2 transcription factor in critical aspects of late megakaryocyte maturation and platelet formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 11012210     DOI: 10.1002/stem.5530140714

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  7 in total

1.  p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.

Authors:  S Deveaux; S Cohen-Kaminsky; R A Shivdasani; N C Andrews; A Filipe; I Kuzniak; S H Orkin; P H Roméo; V Mignotte
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

Review 2.  NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors.

Authors:  Grégory Chevillard; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2011-06-18       Impact factor: 9.261

3.  Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.

Authors:  T Sawado; K Igarashi; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease.

Authors:  Larry J Suva; Eric Hartman; Joshua D Dilley; Susan Russell; Nisreen S Akel; Robert A Skinner; William R Hogue; Ulrich Budde; Kottayil I Varughese; Taisuke Kanaji; Jerry Ware
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

5.  Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy.

Authors:  Anne Schumacher; Bernd Denecke; Till Braunschweig; Jasmin Stahlschmidt; Susanne Ziegler; Lars-Ove Brandenburg; Matthias B Stope; Antons Martincuks; Michael Vogt; Dieter Görtz; Annalisa Camporeale; Valeria Poli; Gerhard Müller-Newen; Tim H Brümmendorf; Patrick Ziegler
Journal:  J Hematol Oncol       Date:  2015-06-09       Impact factor: 17.388

6.  Cell-autonomous function of Runx1 transcriptionally regulates mouse megakaryocytic maturation.

Authors:  Niv Pencovich; Ram Jaschek; Joseph Dicken; Ayelet Amit; Joseph Lotem; Amos Tanay; Yoram Groner
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

7.  Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.

Authors:  Marloes R Tijssen; Ana Cvejic; Anagha Joshi; Rebecca L Hannah; Rita Ferreira; Ariel Forrai; Dana C Bellissimo; S Helen Oram; Peter A Smethurst; Nicola K Wilson; Xiaonan Wang; Katrin Ottersbach; Derek L Stemple; Anthony R Green; Willem H Ouwehand; Berthold Göttgens
Journal:  Dev Cell       Date:  2011-05-17       Impact factor: 12.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.